HA-230 Hemoperfusion Cartridge Cannot Be Directly Used with CRRT Machines
The HA-230 hemoperfusion cartridge is not a standard CRRT component and requires specific technical modifications or tandem configuration to be used alongside CRRT equipment. While hemoperfusion cartridges (like the HA330/HA380 series from the same manufacturer) can be combined with CRRT, this requires either integrated systems or careful circuit modifications.
Technical Feasibility and Configuration
Hemoperfusion cartridges are separate devices from CRRT filters and require distinct setup considerations:
- The HA-series cartridges (HA330, HA380, HA60) contain styrene-divinylbenzene copolymer beads designed for adsorption, not filtration 1
- These cartridges can be connected in tandem with CRRT circuits, typically placed upstream (before) the CRRT filter 2, 3
- Standard CRRT machines are not designed to accommodate hemoperfusion cartridges without modification or additional equipment 4
Clinical Evidence for Combined Use
Recent studies demonstrate that hemoperfusion cartridges from the same manufacturer (HA330/HA380) have been successfully combined with CRRT:
- In sepsis-associated AKI, HA380 combined with CRRT showed maximum IL-6 clearance at 2 hours, with declining efficiency after 12-14 hours 2
- The HA60 cartridge (smaller version) has been used in neonates as small as 2.8 kg when combined with CRRT, demonstrating feasibility in low-weight patients 3
- Combined HP + CRRT showed superior outcomes compared to CRRT alone in poisoning-induced ARF, with shorter time to CRRT independence and better renal recovery 5
Practical Implementation Approach
If you intend to use hemoperfusion with CRRT, follow this algorithm:
- Verify equipment compatibility: Confirm your CRRT machine can accommodate an additional cartridge in series, or use a separate hemoperfusion pump
- Circuit configuration: Place the hemoperfusion cartridge before the CRRT filter in the blood flow path 2
- Anticoagulation strategy: Use regional citrate anticoagulation when possible 6, as recommended for CRRT (Grade 2B), with careful monitoring of ionized calcium when combining therapies
- Timing considerations: Initiate hemoperfusion early (within 4-6 hours for toxin removal) 7 and plan for cartridge replacement at 12-14 hours when adsorption capacity declines 2
- Monitor for complications: Watch for hypocalcemia (occurs in 72% of tandem sessions) 8, antibiotic adsorption requiring dose adjustment 1, and circuit clotting
Critical Caveats
Important limitations you must consider:
- The HA-230 specifically may have different specifications than the well-studied HA330/HA380 cartridges—verify manufacturer guidelines
- Hemoperfusion cartridges adsorb antibiotics, requiring plasma drug level monitoring and potential dose adjustments 1
- Combined extracorporeal circuits increase complexity and risk, particularly hypocalcemia requiring intensive ionized calcium monitoring 8
- Most evidence comes from small observational studies; large randomized trials are ongoing 1
- Standard KDIGO guidelines for CRRT 6 do not specifically address hemoperfusion cartridge integration
The answer depends on your specific CRRT platform and whether you have the technical capability to configure tandem circuits. Contact the HA-230 manufacturer for device-specific compatibility information with your CRRT machine model, as direct integration is not standard practice without proper equipment and training.